January 9, 2009

MERCK & CO: Pursuing Remedies to Avoid CRA’s $160M Penalty

COMPANIES: Merck & Co Inc
Subscribe

Merck & Co., Inc. disclosed in its latest Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission that it is pursuing all appropriate remedies to avoid having the penalty assessed by the Canada Revenue Agency.

Merck’s Canadian…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Earnings | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: New Jersey | United States